Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20260210380286/en/U.S.-Food-and-Drug-Administration-Accepts-New-Drug-Application-and-Grants-Priority-Review-for-Takedas-Oveporexton-TAK-861-as-a-Potential-First-in-Class-Therapy-for-Narcolepsy-Type-1

BUSINESSWIRE
10 Feb 2026